Journal of the Korean Ophthalmological Society 2007;48(4):563-572.
Published online April 30, 2007.
RPE Cell Apoptosis by the Combination Treatment of SAHA and Lactacystin.
Tae Hyun Kim, Chan Soo Park, Jee Hyun Rho, Kyung Won Yoo, Hee Bae Ahn, Woo Chan Park, Su Young Seo, Sae Hyun Rho
1Medical Science Research Center, Dong-A University College of Medicine and Institute of Medical Science, Pusan, Korea.
2Department of Ophthalmology, Dong-A University College of Medicine and Institute of Medical Science, Pusan, Korea. shrho@daunet.donga.ac.kr
사하와 락타시스틴 병합처치에 의한 망막색소상피세포에서의 아폽토시스 연구
김태현1,박찬수2,노지현2,유경원2,안희배2,박우찬2,서수영1,노세현2
Medical Science Research Center1 and Department of Ophthalmology2, Dong-A University College of Medicine and Institute of Medical Science, Pusan, Korea
Correspondence:  Tae Hyun Kim, M.D.1
Abstract
PURPOSE
To establish a new therapeutic strategy for proliferative vitreoretinopathhy (PVR), we examined the effect of combined treatment with HDAC inhibitor SAHA and proteasome inhibitor lactacystin in human retinal pigment epithelial (RPE) cells, ARPE-19. METHODS: Viability was determined by trypan blue exclusion assay. Mitochondrial membrane potential (MMP) was measured by flow cytometry. Proteasome activity was measured by fluorophotometry. The expression and degradation of apoptosis-related proteins were assesssed by Western blotting. Subcellular location of apoptosis-related factors was monitored by confocal miscroscopy. RESULTS: A single treatment with 5 micro M SAHA or 10 micro M lactacystin did not reduce cell viability. However, combination treatment with 5 micro M SAHA and 10 micro M lactacystin substantially reduced the viability, because the mixture induced the reduction of MMP and nuclear condensation or fragmentation. Moreover, the combination treatment triggered the activation of caspase-3 and the production of PARP cleavage products. These data indicate that the combination treatment efficiently induces apoptosis in ARPE-19 cells. However, co-treatment of SAHA did not augment the proteasome inhibitory activity of lactacystin, nor did co-treatment of lactacystin augment acetylation of histones. It is notable that while p53 and CAD were observed in the mitochondria of cells treated with SAHA, they were translocated into the nucleus after the combination treatment. CONCLUSIONS: These results suggest that the combination treatment of SAHA and lactacystin effectively induced apoptosis in ARPE-19 cells. Further work is warranted to develop this combination therapy as a novel therapeutic strategy for PVR.
Key Words: Retinal pigment epithelial cell;PVR;SAHA;Lactacystin
TOOLS
METRICS Graph View
  • 455 View
  • 4 Download
Related articles


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next